BRANCHBURG, N.J. – Feb. 5, 2020 – ZebraSci is pleased to announce that Adam Kalbermatten will join the Company as Chief Executive Officer effective February 10th 2020. Adam will take over the leadership of the company from Robert Schultheis who will continue to lead the ZebraSci Research & Development efforts.
Robert commented, “I am very proud of what our ZebraSci team has accomplished since I founded the company over 10 years ago and that is a credit to the commitment our team has to supporting the needs of healthcare companies and their patients. As we continue to build on our strong foundation and seek to build out our pharmaceutical services business, now is the time to bring in a Chief Executive Offer who can lead the organization and take ZebraSci to the next level. I am confident that Adam is the right person for the job with his extensive experience in pharmaceutical drug delivery systems and services.”
Adam Kalbermatten joins ZebraSci with over 15 years of experience in the pharmaceutical and medical device industry. Most recently, Adam served on the Terumo Pharmaceutical Solutions leadership team as Global Marketing Director where he was responsible for overseeing the business strategy, market development, and promotional activites. Prior to Adam’s role at Terumo, he served in various commercial and operations leadership roles at both BD and Merck. Adam holds a Bachelor of Engineering (BE) in Mechanical Engineering and a Masters of Engineering (ME) in Engineering Management from Stevens Institute of Technology and a Masters of Business Administration (MBA) from Columbia University.
“ZebraSci is the partner of choice for pharmaceutical companies when it comes to qualifying and validating pharmaceutical drug delivery systems to ensure they are safe for healthcare providers and patients.” said Adam Kalbermatten. “I am excited to lead the ZebraSci organization into the next decade and I look forward to partnering with pharmaceutical companies to help bring new treatments to market faster for patients.”
ZebraSci is an ISO 17025 accredited test lab with a quality system that follows CFR 820 and ISO 13485 guidelines. The quality system at ZebraSci is designed to meet the needs of the pharmaceutical industry for primary packaging and device development.
For more information about ZebraSci, please visit our website https://zebrasci.com